| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/28/2013 | US20130317086 Neural transfection reagents |
| 11/28/2013 | US20130317079 Poly(acrylate) Polymers for In Vivo Nucleic Acid Delivery |
| 11/28/2013 | US20130317051 Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent |
| 11/28/2013 | US20130316995 Fatty acid conjugates of statin and fxr agonists; compositions and method of uses |
| 11/28/2013 | US20130316976 Pharmaceutical preparation |
| 11/28/2013 | US20130316975 Inclusion complexes containing piroxicam, a cyclodextrin and arginine |
| 11/28/2013 | US20130316973 Use of lipid conjugates in the treatment of cancer |
| 11/28/2013 | US20130315996 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels |
| 11/28/2013 | US20130315987 Lyophilized liposome composition encapsulating a water-soluble drug and preparation process thereof |
| 11/28/2013 | US20130315980 Cyclodextrin-based materials, compositions and uses related thereto |
| 11/28/2013 | US20130315975 Use of keratinocytes as a biologically active substance in the treatment of wounds, such as diabetic wounds, optionally in combination with a dpp-4 inhibitor |
| 11/28/2013 | US20130315966 Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine Composition |
| 11/28/2013 | US20130315962 Method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmceutical active ingredients |
| 11/28/2013 | US20130315949 Molecular Antigen Array |
| 11/28/2013 | US20130315936 Method for non-invasive treatment of cerebral aneurysms |
| 11/28/2013 | US20130315928 Luteinizing-hormone ligand and ligand-gonadotrophin complex |
| 11/28/2013 | US20130315923 Anti-gcc antibody molecules and related compositions and methods |
| 11/28/2013 | US20130315908 Method for treatment of aneurysms |
| 11/28/2013 | US20130315878 Methods and Compositions Comprising Hyaluronan for Enhancing Bone Marrow Cell Therapy |
| 11/28/2013 | US20130315844 Oral Care Compositions |
| 11/28/2013 | US20130315838 Biomaterials suitable for use as drug eluting, magnetic resonance imaging detectable implants for vascular occlusion |
| 11/28/2013 | US20130315823 Sparc binding peptides and uses thereof |
| 11/27/2013 | EP2666787A1 Stable IgG4 antibodies |
| 11/27/2013 | EP2666482A1 Particle composition and pharmaceutical composition using particle composition |
| 11/27/2013 | EP2666463A1 Stabilized liquid composition comprising pemetrexed |
| 11/27/2013 | EP2666462A1 Radiation cross-linked collagen gel, and preparation method and usage method thereof |
| 11/27/2013 | EP2665736A1 Corona-like (guanidyl)-oligosaccharidic derivatives as cell-penetrating enhancers for intracellular delivery of colloidal therapeutic systems |
| 11/27/2013 | EP2665492A1 (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions |
| 11/27/2013 | EP2665466A1 Solid molecular dispersion |
| 11/27/2013 | EP2665464A2 A carrier for oromucosal, especially sublingual administration of physiologically active substances |
| 11/27/2013 | CN103415307A 透明质酸组合物 Hyaluronic acid composition |
| 11/27/2013 | CN103415284A Pharmaceutical formulation for producing rapidly disintegrating tablets |
| 11/27/2013 | CN103408784A Method for controlling internal morphology of polylactic acid microspheres and polylactic acid microspheres prepared by same |
| 11/27/2013 | CN103408771A Method for preparing PLLA-PEG-PLLA particulates by using SAS process |
| 11/27/2013 | CN103408766A Nanosphere capable of regulating release through oxidative induction and preparation method and application thereof |
| 11/27/2013 | CN103408748A Synthetic method of water-soluble pterostilbene derivative |
| 11/27/2013 | CN103408710A Biodegradable and sugar responsive Y type polymer drug delivery material and preparation |
| 11/27/2013 | CN103408669A Fusion protein of GLP-1 analogue and preparation method and application thereof |
| 11/27/2013 | CN103408665A N-substituted tetrahydropyridine connected-5-substitured indole-monoclonal antibody CD33 conjugate and CD34 conjugate and preparation methods and application thereof |
| 11/27/2013 | CN103408654A rTRAIL (TNT Related Apoptosis-Inducing Ligand) mutant-mPEG-MAL conjugate and application thereof |
| 11/27/2013 | CN103405787A Molecular targeted nucleic acid nano-medicament based on miR-141 (micro ribonucleic acid-141), preparation and application thereof |
| 11/27/2013 | CN103405783A OX26/CTX-PL/pC27 compound and application of OX26/CTX-PL/pC27 compound in treating gliomas |
| 11/27/2013 | CN103405782A Inclusion compound containing celecoxib and preparation method thereof |
| 11/27/2013 | CN103405781A Pharmaceutical composition of compound clindamycin and tazarotene lipid complex |
| 11/27/2013 | CN103405780A Ointment containing tretinoin inclusion compound and clobetasol propionate and preparation method thereof |
| 11/27/2013 | CN103405779A Long-acting artesunate drug for preventing schistosome infection and preparation method thereof |
| 11/27/2013 | CN103405778A Colon-targeted pro-drug based on nanometer cellulose carrier and preparation method of colon-targeted pro-drug |
| 11/27/2013 | CN103405777A Application of HP-beta-CD-GMA-PEI as oral and transpulmonary absorption accelerant |
| 11/27/2013 | CN103405776A Water-soluble coating powder and preparation method thereof |
| 11/27/2013 | CN103405775A Hollow gracilaria polysaccharide capsule and preparation method thereof |
| 11/27/2013 | CN103405774A Novel drug targeting delivery adjuvant |
| 11/27/2013 | CN103405773A Preparation and application of biodegradable thermosensitive in-situ hydrogel |
| 11/27/2013 | CN103405772A Enteric drug film coating premixture and preparation method thereof |
| 11/27/2013 | CN103405766A Bevacizumab eye drop and preparation method thereof |
| 11/27/2013 | CN103405756A Medicine composition-compound digestive enzyme capsule (II) and preparation method thereof |
| 11/27/2013 | CN103405754A Solubilization technology for producing human fibrinogen |
| 11/27/2013 | CN103405746A Gel capable of fast removing acne |
| 11/27/2013 | CN103405610A Compact-type water-soluble human lubricant, preparation method of lubricant and condom |
| 11/27/2013 | CN103405591A Nourishing type water-soluble personal lubricant and preparation method thereof, and condom |
| 11/27/2013 | CN103405537A Health protection product capable of reducing blood fat and improving immunity |
| 11/27/2013 | CN103405510A Compound licorice preparation for eliminating phlegm and relieving cough and preparation method thereof |
| 11/27/2013 | CN103405488A Cataplasm used for treating skin scars, and preparation method thereof |
| 11/27/2013 | CN103405478A Periplaneta americana extract microgel and preparation method thereof |
| 11/27/2013 | CN103405440A Compound anti-AIDS (Acquired Immune Deficiency Syndrome) medicine orally taken suspension preparation |
| 11/27/2013 | CN103405405A Compositions and methods of delivery of pharmacological agents |
| 11/27/2013 | CN103405400A Levosulpiride injection and preparation method thereof |
| 11/27/2013 | CN103405399A Preparation method of paeonol colon targeted nanocapsules |
| 11/27/2013 | CN103405397A Capsule located in bioadhesive drug delivery manner for releasing beta glucosan |
| 11/27/2013 | CN103405396A Zedoary-cyclic-diolefine-containing pharmaceutical composition and pharmacy application thereof |
| 11/27/2013 | CN103405394A Metoprolol tartrate sustained release tablet and preparation method thereof |
| 11/27/2013 | CN103405392A Special injection for sodium fusidate freeze-dried powder injection, and preparation method of special injection |
| 11/27/2013 | CN103405391A BCG polysaccharide nucleic acid freeze-dried powder and preparation method thereof |
| 11/27/2013 | CN103405389A Veterinary menbutone powder and preparation method thereof |
| 11/27/2013 | CN103405388A Wettable moxidectin solid dispersing powder as well as preparation method and application thereof |
| 11/27/2013 | CN103405387A Novel cefixime dry suspension and preparation method thereof |
| 11/27/2013 | CN103405386A Liposome preparation method and method for preparing liposome adjuvant |
| 11/27/2013 | CN103405384A Pharmaceutical composition of tranexamic acid |
| 11/27/2013 | CN103405383A Clindamycin phosphate gel and preparation method thereof |
| 11/27/2013 | CN103405382A Formula and preparation technology of chitosan-iodine suppository |
| 11/27/2013 | CN103405381A Method for preparing amorphous substance |
| 11/27/2013 | CN103083270B Xanthophyll chewable tablet |
| 11/27/2013 | CN102961337B Preparation method of target compound nano particle |
| 11/27/2013 | CN102871968B Preparation of sildenafil rhubarb hydrochloric acid salt medicine granules and preparation of suction type aerosol of gradules |
| 11/27/2013 | CN102847163B Film coating agent for hygroscopic solid traditional Chinese medicine preparation and preparation method thereof |
| 11/27/2013 | CN102847162B Method for preparation of active immunoadsorbent carrier |
| 11/27/2013 | CN102813934B Moistureproof film coating agent for traditional Chinese medicine tablets and preparation method thereof |
| 11/27/2013 | CN102740855B Extended release preparation |
| 11/27/2013 | CN102697744B Allose tablet excipient, medicinal tablet and method for preparing medicinal tablet |
| 11/27/2013 | CN102688525B Bio-macromolecular hydrogel and preparation method thereof |
| 11/27/2013 | CN102688495B Nano particle carrier having tumor and tumor-associated macrophage targeting multiple functions and preparation thereof |
| 11/27/2013 | CN102687964B Method for strengthening drug slow release property in summer sleeping mat |
| 11/27/2013 | CN102657872B Multifunctional graphene oxide/ polyamide-amine (PAMAM)/ diethylene triamine pentaacetic-gadolinium (DTPA-Gd)/ prostate stem cell antigen (PSCA) antibody material and preparation method and application thereof |
| 11/27/2013 | CN102641251B Underwater-dispersible tablet of Sevelamer carbonate |
| 11/27/2013 | CN102641236B Expandable biological adhesive sustained and controlled release preparation for preventing and curing oral diseases and preparation method thereof |
| 11/27/2013 | CN102516397B Interleukin-17 receptor antagonist and application thereof in preparing anti-myocardial fibrosis medicine |
| 11/27/2013 | CN102512656B Quinapril hydrochloride medicinal composition |
| 11/27/2013 | CN102512392B Manidipine hydrochloride solid dispersion, preparation and preparation method of above |
| 11/27/2013 | CN102512387B Zalcitabine drug composition |
| 11/27/2013 | CN102504290B Bead-shaped amphipathic nano particle as well as preparation method and application thereof |
| 11/27/2013 | CN102440974B Olanzapine orally disintegrating pharmaceutical composition |